🇦🇺

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Video Credit: Wochit News
Published on June 30, 2020 - Duration: 00:35s

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies.

The FDA officially announced the medicine could be used in treating COVID-19 patients.

Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals.

Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients.

It could shorten satsy by several days, reports Gizmodo.

Advertisement

You are here


💡 One News Page Knowledge: Other News Mentions



Related videos from verified sources

Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient 00:45
Video credit: Geo Beats - Published on June 29, 2020 

You might like